Welcome to our dedicated page for CXApp SEC filings (Ticker: CXAI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to CXApp Inc. (NASDAQ: CXAI) SEC filings, offering a regulatory view of the company’s AI-powered workplace experience and spatial intelligence business. CXAI’s filings with the U.S. Securities and Exchange Commission include current reports on Form 8-K, annual reports on Form 10-K, quarterly reports on Form 10-Q, and other disclosures that document material events, financial performance, and capital structure.
Recent Form 8-K filings describe financing arrangements such as pre-paid purchase agreements with institutional investors and the related issuance of common stock under exemptions from registration. These documents also confirm that CXAI’s common stock and warrants, trading under the symbols CXAI and CXAIW, are registered under Section 12(b) of the Exchange Act and listed on The Nasdaq Stock Market LLC. Investors can use these filings to understand how CXAI funds its operations, manages obligations, and reports significant corporate developments.
For a broader perspective, CXAI’s periodic reports typically outline its SaaS business model, the importance of recurring subscription revenue, and the role of Agentic AI and spatial intelligence in its workplace platform. They may also discuss risk factors, customer concentration, intellectual property, and other elements relevant to an enterprise software and data processing company.
On Stock Titan, SEC documents are paired with AI-powered summaries that highlight key points, explain complex sections in plain language, and help readers quickly identify items such as revenue mix, capital transactions, and material agreements. Real-time updates from EDGAR ensure that new 10-K, 10-Q, 8-K, and Form 4 insider transaction filings appear promptly, while AI-generated insights make it easier to interpret how each filing fits into CXAI’s overall corporate and financial profile.
CXApp Inc. provides an AI-powered, mobile-first employee experience SaaS platform that helps enterprises manage hybrid workplaces, space utilization and engagement, backed by 37 filed patents, including 17 granted. Customers are largely Fortune 1000 firms across technology, financial services, manufacturing, entertainment and life sciences.
The company remains unprofitable, with net losses of $13.5 million in 2025 and $19.4 million in 2024, and a workforce of about 35 employees as of March 24, 2026. It recorded a $2.1 million goodwill impairment in 2025 and depends heavily on a few large customers; the top three represented about 40% of 2025 revenue.
CXApp previously reported material weaknesses in internal control but states these were remediated by December 31, 2025. Its stock faces Nasdaq minimum bid price noncompliance, with an extension to September 7, 2026 to regain a bid of at least $1.00 for 10 consecutive business days, or risk delisting.
CXApp Inc. reported issuing 10,028,891 shares of common stock to Avondale Capital, LLC in a private transaction under prior pre-paid purchase arrangements tied to a 2025 securities purchase agreement. The shares were delivered on multiple dates in February and March 2026 at prices between $0.156793 and $0.199381 per share, relying on an exemption from Securities Act registration for transactions not involving a public offering.
CXApp Inc. disclosed that Nasdaq has granted it an additional 180-day grace period, until September 7, 2026, to regain compliance with Nasdaq’s minimum bid price rule. The company’s stock had traded below the required $1.00 per share for at least 30 consecutive business days, triggering the deficiency notice.
The extension allows CXApp’s common stock to continue trading on the Nasdaq Capital Market while it works to cure the issue. The company has informed Nasdaq it intends to address the deficiency, potentially through a reverse stock split if needed. If the closing bid is at or above $1.00 for at least ten consecutive trading days before the deadline, compliance will be restored. Failure to do so could lead to delisting, although CXApp would have the right to appeal.
CXApp Inc. files a prospectus supplement registering the resale of up to 10,026,776 shares of common stock. The supplement also covers resale of up to 10,280,000 private placement warrants, 24,080,000 shares of common stock underlying warrants, and specified resale rights of Streeterville Capital under existing agreements.
The supplement incorporates a Form 8-K reporting that Nasdaq granted an additional compliance period through September 7, 2026 to meet the $1.00 minimum bid price requirement; the company reported closing prices of $0.21 per share and $0.066 per warrant on March 11, 2026.
CXApp Inc. reported that it issued 4,616,481 shares of its common stock to Avondale Capital, LLC in a private transaction. The shares were delivered under a Pre-Paid Purchase #1 dated March 26, 2025, entered into pursuant to a Securities Purchase Agreement between the two parties.
The common shares were issued on January 26, 2026, January 27, 2026 and January 28, 2026 at a price of $0.24024 per share. CXApp relied on Section 4(a)(2) of the Securities Act of 1933, using an exemption for transactions not involving a public offering, which means these shares were sold without SEC registration and increase the company’s outstanding share count.
CXApp Inc. filed a prospectus supplement covering the resale of up to 10,026,776 shares of common stock, 10,280,000 warrants, and 24,080,000 shares of common stock underlying those warrants by selling securityholders. The supplement incorporates a Current Report on Form 8-K.
The attached Form 8-K discloses that CXApp issued 4,616,481 shares of common stock to Avondale Capital, LLC under a pre-paid purchase agreement at $0.24024 per share, with issuances on January 26, 27 and 28, 2026, relying on the private offering exemption in Section 4(a)(2) of the Securities Act. CXApp’s common stock and warrants trade on Nasdaq under the symbols CXAI and CXAIW, with recent closing prices of $0.305 per share and $0.0327 per warrant, respectively.
CXApp Inc. has filed a prospectus supplement covering the resale of up to 10,026,776 shares of common stock, along with 10,280,000 warrants and 24,080,000 shares of common stock underlying those warrants by existing securityholders. The supplement incorporates a new current report and must be read together with the base prospectus dated October 3, 2024.
Separately, CXApp disclosed that it issued 3,266,615 shares of common stock to Avondale Capital, LLC under a pre-paid purchase arrangement, at a price of $0.348985 per share, in a private offering relying on an exemption from registration. The company’s common stock and warrants trade on Nasdaq under the symbols CXAI and CXAIW, with recent closing prices of $0.4654 per share and $0.0778 per warrant.
CXApp Inc. reported that it issued 3,266,615 shares of common stock to Avondale Capital, LLC at a price of $0.348985 per share in an unregistered, non-public offering. The shares were delivered on December 9, 2025 and December 10, 2025 under a Pre-Paid Purchase #1 dated March 26, 2025, which is tied to a Securities Purchase Agreement between the two parties.
The company states that the offer and sale were conducted in reliance on Section 4(a)(2) of the Securities Act for transactions not involving a public offering, meaning the shares were not registered with the SEC for public sale. CXApp also reiterates a broad set of business risks and uncertainties, including demand for its services, competitive pressures, regulatory changes, management continuity, and potential loss of major customers.
CXApp Inc. filed a prospectus supplement for the resale of up to 10,026,776 shares of common stock, together with 10,280,000 warrants and 24,080,000 shares issuable upon warrant exercise, by selling securityholders. Components include 6,977,776 previously issued shares, 10,280,000 private placement warrants, 13,800,000 public-warrant shares and 10,280,000 private-warrant shares, plus up to 40,000 shares and up to 3,009,000 shares related to a May 22, 2024 financing.
The supplement attaches CXApp’s quarterly report. For the quarter ended September 30, 2025, revenue was $1.114 million versus $1.897 million a year ago, with a net loss of $3.157 million versus $5.434 million. Cash and cash equivalents were $5.088 million. Management disclosed recurring losses and cash use that raise doubt about continuing as a going concern, while citing financing arrangements and cost actions to support operations. As of November 11, 2025, shares outstanding were 28,629,315.
CXApp’s securities trade on Nasdaq as CXAI (common) and CXAIW (warrants).
CXApp Inc. (CXAI) filed its Q3 2025 10‑Q, reporting lower revenue and a narrower quarterly loss. Revenue was $1.114 million versus $1.897 million a year ago as subscription activity dominated. Gross profit was $0.991 million. Operating loss totaled $3.825 million, and net loss was $3.157 million for the quarter. For the nine months, revenue was $3.561 million (prior year $5.481 million) with a net loss of $7.912 million.
Cash and cash equivalents were $5.088 million with a working capital deficiency of about $0.711 million. Operating cash use was $6.750 million year‑to‑date, offset by $6.990 million of financing inflows. The company highlighted substantial funding access: an Avondale agreement for up to $20.000 million (remaining $12.650 million as of September 30, 2025) and $3.520 million remaining under a Streeterville facility. It also filed an S‑3 shelf for up to $150.000 million and a prospectus supplement enabling up to $7.959 million of common stock issuance. Management noted recurring losses and cash use raise doubt about going concern, but estimates available cash and committed funding will sustain operations through Q4 2026. Class A shares outstanding were 25,850,177 as of September 30, 2025; 28,629,315 as of November 11, 2025.